Bodyport Receives 510(k) Clearance for Cardiac Scale

Bodyport has received 510(k) clearance from the FDA for its Cardiac Scale device.

The scale, which detects cardiac function and fluid status, is for use by patients with fluid management conditions that include heart failure and kidney disease.

When a patient steps on the scale, advanced algorithms measure hemodynamic biomarkers and the scale transmits the data to the patient’s healthcare team, enabling them to deliver effective care.

The new scale can dramatically improve how patients with heart failure are currently managed, according to Bodyport CEO John Lipman. Patients with heart failure currently have few options apart from “a standard weight scale or a costly and invasive implant,” he said.